Expert Interview
A look at theranostic imaging and Targeted Alpha Therapy.
Ticker(s): LNTH, NVS, RYZB, PNTInstitution: Edmonton Radiopharmaceutical Center
- Director and Senior Radiochemist at Edmonton Radiopharmaceutical Center as well as Adjunct at University of Alberta
- Expertise in radioligand development, process development and validation using designed experiments and quality by design, analytical methods, quality assurance, cyclotron operations and maintenance.
- Research interest in radiopharmacy, radiochemistry as well as cyclotron production of novel radionuclides.
Can you discuss which actinium based radiotherapies in development most excite you?
Added By: sara_adminCan you explain the pros and cons of specific approaches to radioligand therapies such as; using antibodies, small molecules, or other targeting moieties?
Added By: sara_adminAny thoughts on how Bristol Myers Squibb's acquisition of Rayze Bio will be impactful to the radiopharmaceutical industry?
Added By: sara_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
